Article

Safety, tolerability, bioavailability, and biological activity of inhaled interferon-α2b in healthy adults: The IN2COVID phase 1 randomized trial

2022-09-23

Abstract excerpt

<h4>Aim: </h4> Interferons (IFNs) have been identified as a potential treatment alternative for Coronavirus Disease 19 (COVID-19). This study assessed the safety, tolerability, bioavailability, and biological activity of inhaled interferon-α2b (IFN-α2b) in healthy adults. <h4>Methods:</h4> A double-blind, randomized, phase 1 clinical trial was conducted with two cohorts of healthy subjects aged 18-50 years old. Th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 583d95cd-deec-53b9-8ec1-7b9ba71bbad3
DOI: 10.22541/au.166332788.86613370/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Safety, tolerability, bioavailability, and biological activity of inhaled interferon-α2b in healthy adults: The IN2COVID phase 1 randomized trialDOI 10.22541/au.166332788.86613370/v2Read

Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial.Semantic proximity Read

Safety and pharmacodynamics of intranasal administration of recombinant human interferon alfa-2b as a potential prophylactic for SARS-CoV-2 infection in an at-risk group: a phase I-II clinical trial, open, uncontrolled, in a single-arm (OLIVO Study)Semantic proximity Read

The type I interferon response in COVID-19: implications for treatmentSemantic proximity Read

Protective Potentials of Type III Interferons in COVID-19 Patients: Lessons from Differential Properties of Type I- and III InterferonsSemantic proximity Read

Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial CulturesSemantic proximity Read

A single blinded, phase IV, adaptive randomised control trial to evaluate the safety of coadministration of seasonal influenza and COVID-19 vaccines (The FluVID study)Semantic proximity Read

A randomized, placebo-controlled trial of a nasal spray solution containing broadly potent neutralizing antibodies against SARS-CoV-2 variants in healthy volunteersSemantic proximity Read

Favipiravir and/or Nitazoxanide: a randomized, double-blind, 2x2 design, placebo-controlled trial of early therapy in COVID-19 (FANTAZE).Semantic proximity Read

Endogenous interferon-beta but not interferon-alpha or interferon-lambda levels in nasal mucosa predict clinical outcome in critical COVID-19 patients independent of viral loadSemantic proximity Read

Differential interferon-α subtype immune signatures suppress SARS-CoV-2 infectionSemantic proximity Read

Developing Interferon-β as a safe in-vivo experimental-medicine model of human inflammationSemantic proximity Read

Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responsesSemantic proximity Read